
Celldex Therapeutics CLDX
€ 22.37
2.35%
Quartalsbericht 2025-Q3
hinzugefügt 10.11.2025
Celldex Therapeutics P/B 2011-2026 | CLDX
P/B Jährlich Celldex Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00176 | 0.00542 | 0.00614 | 0.00317 | 0.00306 | 0.356 | 0.518 | 1.52 | 1.24 | 2.78 | 9.05 | 6.59 | 4.39 | 2.58 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 9.05 | 0.00176 | 2.07 |
P/B anderer Aktien in der Pharmaeinzelhändler
| Name | P/B | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M | ||
|
Adagene
ADAG
|
1.74 | $ 2.45 | -1.61 % | $ 138 M | ||
|
Acorda Therapeutics
ACOR
|
0.154 | - | -24.86 % | $ 820 K | ||
|
Biogen
BIIB
|
1.16 | $ 172.45 | 0.5 % | $ 25.1 B | ||
|
Aptorum Group Limited
APM
|
0.347 | $ 0.97 | 0.81 % | $ 5.29 M | ||
|
Alterity Therapeutics Limited
ATHE
|
125 | $ 3.65 | 2.82 % | $ 8.78 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M | ||
|
BioNTech SE
BNTX
|
5.29 | $ 117.57 | 1.37 % | $ 27.2 B | ||
|
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | ||
|
Akero Therapeutics
AKRO
|
4.34 | - | - | $ 3.67 B | ||
|
BioXcel Therapeutics
BTAI
|
-0.0577 | $ 1.79 | -1.64 % | $ 4.54 M | ||
|
BioLineRx Ltd.
BLRX
|
19.9 | $ 2.94 | -5.16 % | $ 908 M | ||
|
Applied Molecular Transport
AMTI
|
0.364 | - | - | $ 10.1 M | ||
|
Catalyst Biosciences
CBIO
|
0.428 | $ 12.13 | -5.23 % | $ 799 M | ||
|
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - | ||
|
Ascendis Pharma A/S
ASND
|
8.34 | $ 233.71 | -0.71 % | $ 5 B | ||
|
Burford Capital Limited
BUR
|
1.26 | $ 9.81 | 0.56 % | $ 1.57 B | ||
|
ARCA biopharma
ABIO
|
1.27 | - | 1052.0 % | $ 415 M | ||
|
Acasti Pharma
ACST
|
0.612 | - | 4.01 % | $ 150 M | ||
|
Arrowhead Pharmaceuticals
ARWR
|
4.51 | $ 67.35 | 0.45 % | $ 9.01 B | ||
|
Compugen Ltd.
CGEN
|
2.26 | $ 2.06 | -1.67 % | $ 184 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
32 | $ 4.43 | -0.78 % | $ 9.64 B | ||
|
Aeterna Zentaris
AEZS
|
0.781 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
0.00262 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | ||
|
Akouos
AKUS
|
0.736 | - | 0.23 % | $ 488 M | ||
|
Cellectis S.A.
CLLS
|
0.531 | $ 4.16 | -6.94 % | $ 116 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
51.9 | - | -15.15 % | $ 60.3 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.79 | $ 25.89 | -0.14 % | $ 1.25 B | ||
|
Coherus BioSciences
CHRS
|
-1.08 | $ 2.28 | 10.68 % | $ 215 M | ||
|
Amneal Pharmaceuticals
AMRX
|
0.522 | $ 13.48 | 0.67 % | $ 4.17 B | ||
|
AIkido Pharma
AIKI
|
0.492 | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
3.06 | - | -0.23 % | $ 916 M | ||
|
CureVac N.V.
CVAC
|
5.13 | - | - | $ 867 M | ||
|
Aptose Biosciences
APTO
|
-0.511 | - | -45.71 % | $ 1.2 M | ||
|
Acer Therapeutics
ACER
|
-0.724 | - | 2.71 % | $ 14 M | ||
|
Aravive
ARAV
|
5.67 | - | -13.39 % | $ 1.45 M | ||
|
Alpine Immune Sciences
ALPN
|
1.5 | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
0.432 | - | 4.14 % | $ 49.1 M | ||
|
Athira Pharma
ATHA
|
0.36 | - | - | $ 269 M | ||
|
Ampio Pharmaceuticals
AMPE
|
0.198 | - | -11.43 % | $ 502 K | ||
|
AVROBIO
AVRO
|
0.594 | - | 1083.1 % | $ 745 M | ||
|
Ayala Pharmaceuticals
AYLA
|
0.994 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
0.127 | $ 2.74 | 1.48 % | $ 17.2 M | ||
|
AstraZeneca PLC
AZN
|
2.07 | $ 94.2 | 1.34 % | $ 96.9 B | ||
|
Arena Pharmaceuticals
ARNA
|
7.2 | - | -6.81 % | $ 3.04 B | ||
|
Brickell Biotech
BBI
|
0.982 | - | -5.38 % | $ 6.06 M |